Axonal damage induced by cerebrospinal fluid from patients with relapsing-remitting multiple sclerosis

被引:53
|
作者
Alcázar, A
Regidor, I
Masjuan, J
Salinas, M
Alvarez-Cermeño, JC
机构
[1] Hosp Ramon & Cajal, Serv Neurol, E-28034 Madrid, Spain
[2] Hosp Ramon & Cajal, Serv Bioquim Invest, E-28034 Madrid, Spain
[3] Univ Alcala de Henares, Dept Med, Alcala De Henares, Spain
关键词
apoptosis; axonal damage; cerebrospinal fluid; cultured neurons; multiple sclerosis;
D O I
10.1016/S0165-5728(99)00225-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The importance of axonal damage in multiple sclerosis (MS) has been recently stressed in proton magnetic resonance spectroscopy and pathological studies, but the exact mechanism producing this damage is unknown. The aim of our study was to ascertain whether soluble mediators present in the cerebrospinal fluid (CSF) of patients with relapsing-remitting MS could induce neuron injury in culture. Different biochemical and cytochemical parameters were determined in primary embryonal rat neuron cultures following 8 days of exposure to CSF. Cytotoxic activity was evaluated with a blue formazan production colorimetric assay. Morphological and immunocytochemical studies performed with antibodies against beta-tubulin revealed neuritic fragmentation, axonal damage and cellular shrinkage indicating apoptosis, Detection of apoptosis was carried out using the fluorescent DNA-binding dye Hoechst 33342, as well as by a Terminal deoxynucleotidyl transferase-mediated dUTP Nick End-Labeling assay. We observed that soluble factors in CSF from patients with "aggressive" MS i.e, those with poor recovery after relapses, induced neurite breakdown and neuronal apoptosis in cultures. Neuron injury is not related with blood-brain barrier dysfunction nor with IgG index. Interestingly, CSF from patients with "non-aggressive" MS i.e., relapsing-remitting patients with a good recovery after relapses, did not induce any damage. In conclusion, we report that CSF from patients with aggressive MS bears soluble mediators that induce axonal damage and apoptosis of neurons in culture. These mediators can be present during the first attack of the disease, and the neuronal damage caused could be related to the functional deficit of these MS patients. (C) 2000 Published by Elsevier Science B.V. All rights reserved.
引用
收藏
页码:58 / 67
页数:10
相关论文
共 50 条
  • [31] MICROBIOME CORE IN PATIENTS WITH RELAPSING-REMITTING MULTIPLE SCLEROSIS
    Navarro-Lopez, V.
    Mingot, J. M.
    Carrion-Gutierrez, M.
    Paya-Espinosa, Y.
    Ruzafa Costa, B.
    Nunez Delegido, E.
    ANNALS OF NUTRITION AND METABOLISM, 2018, 72 : 56 - 57
  • [32] Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis
    Onder, Halil
    TURKISH JOURNAL OF NEUROLOGY, 2019, 25 (02) : 105 - 106
  • [33] Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis - Results of a longitudinal magnetic resonance spectroscopy study
    De Stefano, N
    Matthews, PM
    Fu, LQ
    Narayanan, S
    Stanley, J
    Francis, GS
    Antel, JP
    Arnold, DL
    BRAIN, 1998, 121 : 1469 - 1477
  • [34] Cognitive dysfunction in patients with relapsing-remitting multiple sclerosis
    Nocentini, U
    Pasqualetti, P
    Bonavita, S
    Buccafusca, M
    De Caro, MF
    Farina, D
    Girlanda, P
    Le Pira, F
    Lugaresi, A
    Quattrone, A
    Reggio, A
    Salemi, G
    Savettieri, G
    Tedeschi, G
    Trojano, M
    Valentino, P
    Caltagirone, C
    MULTIPLE SCLEROSIS, 2006, 12 (01): : 77 - 87
  • [35] Prevalence of Depression in Patients with Relapsing-remitting Multiple Sclerosis
    Iranmanesh, F.
    MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (04) : 523 - 523
  • [36] Subclinical atherosclerosis in patients with relapsing-remitting multiple sclerosis
    Tomaž Omerzu
    Jožef Magdič
    Radovan Hojs
    Uroš Potočnik
    Mario Gorenjak
    Tanja Hojs Fabjan
    Wiener klinische Wochenschrift, 2024, 136 : 40 - 47
  • [37] Cognitive resiliency in relapsing-remitting multiple sclerosis patients
    Harel, Y.
    Achiron, A.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S212 - S212
  • [38] Teriflunomide in Patients with Relapsing-Remitting Forms of Multiple Sclerosis
    Chan, Andrew
    de Seze, Jerome
    Comabella, Manuel
    CNS DRUGS, 2016, 30 (01) : 41 - 51
  • [39] Cardiovascular abnormalities in patients with relapsing-remitting multiple sclerosis
    El-Ghoneimy, Lobna Ahmed Talaat
    Shalaby, Nevin
    Elmazny, Alaa
    El-Baghdady, Yasser
    Shehata, Hatem
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (02) : NP3 - NP3
  • [40] Depression in relapsing-remitting multiple sclerosis
    Mendes, MF
    Tilbery, CP
    Balsimelli, S
    Moreira, MA
    Barao-Cruz, AM
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2003, 61 (3A) : 591 - 595